NGB2904 is a potent, selective, orally active, and blood-brain barrier permeable dopamine D3 receptor antagonist (Ki = 1.4 nM); it exhibits high selectivity for D3 over D2, 5-HT2, α1, D4, D1, and D5 receptors (Ki = 217, 223, 642, >5000, >10000, and >10000 nM, respectively); it antagonizes quinpirole-stimulated mitogenesis.